申请人:Purdue Pharma L.P.
公开号:US20150259293A1
公开(公告)日:2015-09-17
The invention relates to substituted pyridine compounds of Formula (I) and the pharmaceutically acceptable salts, prodrugs, and solvates thereof, wherein R
1a
, A
1
, A
2
, E, G, Z
1
, and Z
2
are defined as set forth in the specification. The invention is also directed to the use of compounds of Formula I to treat a disorder responsive to the blockade of sodium channels. Compounds of the present invention are especially useful for treating pain.
本发明涉及式(I)的取代吡啶化合物及其药学上可接受的盐、前药和溶剂化物,其中R1a、A1、A2、E、G、Z1和Z2如规范中所述。本发明还涉及使用式(I)的化合物来治疗对钠通道阻滞有反应的疾病。本发明的化合物特别适用于治疗疼痛。